Ron Firestein

8.5k total citations · 1 hit paper
59 papers, 4.3k citations indexed

About

Ron Firestein is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ron Firestein has authored 59 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 21 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Ron Firestein's work include Cancer-related gene regulation (8 papers), Cancer Cells and Metastasis (7 papers) and Ubiquitin and proteasome pathways (7 papers). Ron Firestein is often cited by papers focused on Cancer-related gene regulation (8 papers), Cancer Cells and Metastasis (7 papers) and Ubiquitin and proteasome pathways (7 papers). Ron Firestein collaborates with scholars based in United States, Australia and France. Ron Firestein's co-authors include Michael L. Cleary, William C. Hahn, Tony Kouzarides, Andrew J. Bannister, Uta‐Maria Bauer, Robert Schneider, Ashby J. Morrison, Søren Jensby Nielsen, Rafael E. Herrera and Thomas Jenuwein and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ron Firestein

57 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rb targets histone H3 methylation and HP1 to promoters

2001 706 citations Ron Firestein, Michael L. Cleary et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ron Firestein United States	35	2.9k	1.2k	679	516	384	59	4.3k
Chia‐Hsin Chan United States	27	3.1k 1.1×	1.2k 1.0×	741 1.1×	412 0.8×	124 0.3×	39	3.8k
Sarki A. Abdulkadir United States	38	2.6k 0.9×	1.2k 1.0×	881 1.3×	259 0.5×	447 1.2×	93	4.4k
Christopher Brooks United States	26	3.6k 1.2×	2.9k 2.4×	671 1.0×	375 0.7×	387 1.0×	85	5.3k
Adam S. Adler United States	26	1.9k 0.6×	575 0.5×	578 0.9×	241 0.5×	587 1.5×	40	3.5k
Xuanmao Jiao United States	30	1.8k 0.6×	1.3k 1.1×	655 1.0×	342 0.7×	125 0.3×	58	3.0k
Chrysiis Michaloglou United Kingdom	8	3.3k 1.1×	1.4k 1.1×	810 1.2×	496 1.0×	103 0.3×	12	5.5k
Dung‐Fang Lee United States	36	4.9k 1.7×	1.6k 1.3×	1.4k 2.1×	416 0.8×	89 0.2×	87	6.3k
Giovanna Chiorino Italy	37	3.0k 1.0×	1.3k 1.1×	1.3k 1.9×	344 0.7×	72 0.2×	113	4.8k
Lixin Wan United States	37	3.5k 1.2×	1.3k 1.1×	746 1.1×	783 1.5×	59 0.2×	66	4.3k
Thomas Kuilman Netherlands	16	3.8k 1.3×	1.9k 1.6×	1.2k 1.8×	519 1.0×	116 0.3×	25	6.7k

Countries citing papers authored by Ron Firestein

Since Specialization

Citations

This map shows the geographic impact of Ron Firestein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Firestein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Firestein more than expected).

Fields of papers citing papers by Ron Firestein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron Firestein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Firestein. The network helps show where Ron Firestein may publish in the future.

Co-authorship network of co-authors of Ron Firestein

This figure shows the co-authorship network connecting the top 25 collaborators of Ron Firestein. A scholar is included among the top collaborators of Ron Firestein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron Firestein. Ron Firestein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liang, Yuqing, et al.. (2024). Emerging and Biological Concepts in Pediatric High-Grade Gliomas. Cells. 13(17). 1492–1492. 3 indexed citations

Voon, Hsiao P. J., Linda Hii, Maheshi Udugama, et al.. (2023). Pediatric glioma histone H3.3 K27M/G34R mutations drive abnormalities in PML nuclear bodies. Genome biology. 24(1). 284–284. 12 indexed citations

Firestein, Ron, et al.. (2023). A protocol to establish cell line models from rare pediatric solid tumors. STAR Protocols. 4(3). 102537–102537. 3 indexed citations

Almasabi, Saleh, et al.. (2023). Integrin-linked kinase expression in myeloid cells promotes colon tumorigenesis. Frontiers in Immunology. 14. 1270194–1270194. 3 indexed citations

Doan, Anh, Daniel J. Garama, Marius Dannappel, et al.. (2021). MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinase. Molecular Cell. 82(1). 123–139.e7. 21 indexed citations

Scheltinga, Anton G.T. Terwisscha van, Annie Ogasawara, Glenn Pacheco, et al.. (2016). Preclinical Efficacy of an Antibody–Drug Conjugate Targeting Mesothelin Correlates with Quantitative 89Zr-ImmunoPET. Molecular Cancer Therapeutics. 16(1). 134–142. 33 indexed citations

Asundi, Jyoti, Lisa Crocker, Jarrod R. Tremayne, et al.. (2015). An Antibody–Drug Conjugate Directed against Lymphocyte Antigen 6 Complex, Locus E (LY6E) Provides Robust Tumor Killing in a Wide Range of Solid Tumor Malignancies. Clinical Cancer Research. 21(14). 3252–3262. 28 indexed citations

Ryner, Lisa, Yinghui Guan, Ron Firestein, et al.. (2015). Upregulation of Periostin and Reactive Stroma Is Associated with Primary Chemoresistance and Predicts Clinical Outcomes in Epithelial Ovarian Cancer. Clinical Cancer Research. 21(13). 2941–2951. 86 indexed citations

Wang, Xi, et al.. (2015). Castration-Resistant Lgr5+ Cells Are Long-Lived Stem Cells Required for Prostatic Regeneration. Stem Cell Reports. 4(5). 768–779. 34 indexed citations

10.

Storm, Elaine E., Steffen Durinck, Felipe de Sousa e Melo, et al.. (2015). Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function. Nature. 529(7584). 97–100. 181 indexed citations

11.

Danila, Daniel C., Howard I. Scher, Edith Szafer‐Glusman, et al.. (2015). Abstract 4310: Predictive biomarkers of tumor sensitivity to STEAP1 antibody-drug conjugate (ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). Cancer Research. 75(15_Supplement). 4310–4310. 1 indexed citations

12.

Scales, Suzie J., Nidhi Gupta, Glenn Pacheco, et al.. (2014). An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models. Molecular Cancer Therapeutics. 13(11). 2630–2640. 52 indexed citations

13.

Scales, Suzie J., Nidhi Gupta, Glenn Pacheco, et al.. (2014). Abstract 4494: A clinical candidate anti-mesothelin-MMAE antibody-drug conjugate (ADC) for therapy of mesothelin-expressing cancers. Cancer Research. 74(19_Supplement). 4494–4494. 1 indexed citations

14.

Lau, Ted, Emily Chan, Marinella Callow, et al.. (2013). A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation–Driven Colorectal Tumor Growth. Cancer Research. 73(10). 3132–3144. 256 indexed citations

15.

McCleland, Mark L., Adam S. Adler, Ely Cosino, et al.. (2012). Lactate Dehydrogenase B Is Required for the Growth of KRAS-Dependent Lung Adenocarcinomas. Clinical Cancer Research. 19(4). 773–784. 93 indexed citations

16.

McCleland, Mark L., Adam S. Adler, Yonglei Shang, et al.. (2012). An Integrated Genomic Screen Identifies LDHB as an Essential Gene for Triple-Negative Breast Cancer. Cancer Research. 72(22). 5812–5823. 150 indexed citations

17.

Adler, Adam S., Mark L. McCleland, Tom Truong, et al.. (2012). CDK8 Maintains Tumor Dedifferentiation and Embryonic Stem Cell Pluripotency. Cancer Research. 72(8). 2129–2139. 80 indexed citations

18.

Asundi, Jyoti, Chae Reed, Krista McCutcheon, et al.. (2011). An Antibody–Drug Conjugate Targeting the Endothelin B Receptor for the Treatment of Melanoma. Clinical Cancer Research. 17(5). 965–975. 44 indexed citations

19.

Firestein, Ron, Gil Blander, Shaday Michán, et al.. (2008). The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth. PLoS ONE. 3(4). e2020–e2020. 477 indexed citations

20.

Firestein, Ron, Xiangmin Cui, Phil Huie, & Michael L. Cleary. (2000). Set Domain-Dependent Regulation of Transcriptional Silencing and Growth Control by SUV39H1, a Mammalian Ortholog of Drosophila Su(var)3-9. Molecular and Cellular Biology. 20(13). 4900–4909. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact